Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Consumer Private Placement and M&A Transactions Review Week Ending April 28, 2024

Consumer Private Placement and M&A Transactions Review Week Ending April 28, 2024

by Jonathan Hodson-Walker | May 2, 2024 | Consumer

Strategy | Financing Transactions Private Placement / Financing Transactions The Borders Distillery: The company raised GBP 35 million of venture funding from Ferovinum on April 22, 2024. The company specializes in producing whisky, gin, and vodka. Wilde Chips: The...
Healthcare Private Placement and M&A Transactions Review Week Ending April 28, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending April 28, 2024

by Jonathan Hodson-Walker | May 2, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Cerevance: The company raised $163 million of Series B venture funding in a deal led by Agent Capital, Bioluminescence Ventures and Double Point Ventures on April 25, 2024. GV, Takeda...
Consumer Private Placement and M&A Transactions Review Week Ending April 21, 2024

Consumer Private Placement and M&A Transactions Review Week Ending April 21, 2024

by Jonathan Hodson-Walker | Apr 25, 2024 | Consumer

Strategy | Financing Transactions Private Placement / Financing Transactions ByHeart: The company raised $80 million of venture funding from Bellco Capital, Sonostar Ventures and AF Ventures on April 8, 2024. Polaris Partners, OCV Partners and D1 Capital Partners also...
Healthcare Private Placement and M&A Transactions Review Week Ending April 21, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending April 21, 2024

by Jonathan Hodson-Walker | Apr 25, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158.3 million of Series B venture funding in a deal led by Deep Track Capital on April 10, 2024. Bristol-Myers Squibb, Perceptive Xontogeny Venture...
Technology Private Placement and M&A Transactions Review Week Ending April 21, 2024

Technology Private Placement and M&A Transactions Review Week Ending April 21, 2024

by Jonathan Hodson-Walker | Apr 11, 2024 | Technology

Strategy | Financing Transactions Private Placement / Financing Transactions Dude Perfect: The company received an estimated $100 million of development capital from Highmount Capital and Pittco Management on April 9, 2024. The company is an operator of a sports and...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending February 8, 2026
  • Consumer Private Placement and M&A Transactions Review Week Ending February 8, 2026
  • Healthcare Private Placement and M&A Transactions Review Week Ending February 8, 2026
  • Technology Private Placement and M&A Transactions Review Week Ending February 1, 2026
  • Consumer Private Placement and M&A Transactions Review Week Ending February 1, 2026

Categories

Archives